Trial intelligence / Profile preview

ED50 of esketamine combined with propofol for pediatric painless gastroscopy

ChiCTR2100052830Phase 4Recruiting

Sponsor
Binzhou Medical University Hospital
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of esketamine and propofol in procedural pain and anxiety disorder, sponsored by Binzhou Medical University Hospital. Primary endpoint: Esketamine dosage (ED50). Started Nov 2021; status: recruiting.

02

Drugs

esketaminepropofol
03

Conditions

procedural painanxiety disorder

Beyond the preview

Go deeper on ChiCTR2100052830.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100052830.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call